Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.
Creates an independent Life Sciences Research Security Board to review and approve Federal funding for "high-risk life sciences research." The Board has binding authority to permit, pause, or require changes to federally funded research involving defined high-consequence pathogens, dual-use concerns, or gain-of-function work. The statute defines covered research categories, sets Board composition, requires agency notification and recipient attestations, mandates review timelines and penalties for false attestations, authorizes annual appropriations, and requires congressional briefings and GAO audits.
Progressives emphasize public-health and biosecurity protections
Creates new independent oversight with broad authority and operational burdens likely to alarm research stakeholders and some lawmakers.
Creates an independent Life Sciences Research Security Board to review and approve Federal funding for "high-risk life sciences research." The Board has binding authority to permit, pause, or require changes to federally funded research involving defined high-consequence pathogens, dual-use concerns, or gain-of-function work.
The statute defines covered research categories, sets Board composition, requires agency notification and recipient attestations, mandates review timelines and penalties for false attestations, authorizes annual appropriations, and requires congressional briefings and GAO audits.
Substantive restructuring of grant oversight with high controversy, stakeholder opposition, and novel federal authority reduces likelihood despite bipartisan security appeal.
How solid the drafting looks.
Progressives emphasize public-health and biosecurity protections
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize public-health and biosecurity protections
Likely views the bill as a needed safety and oversight mechanism to prevent dangerous biological work and protect public health.
Support would depend on assurance that review prevents misuse while preserving beneficial research and equitable access to public-health science.
Treats the bill as a pragmatic attempt to balance national security and public-health safety with scientific progress.
Support would hinge on predictable timelines, clear definitions, and robust emergency expedited-review procedures to avoid unnecessary delays.
Likely views the bill skeptically as an expansion of federal power that can override agency decisions and hinder research innovation.
Support might be contingent on narrowing scope and increasing agency and state control.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Substantive restructuring of grant oversight with high controversy, stakeholder opposition, and novel federal authority reduces likelihood despite bipartisan security appeal.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize public-health and biosecurity protections
Substantive restructuring of grant oversight with high controversy, stakeholder opposition, and novel federal authority reduces likelihood…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Risky Research Review Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.